Brief: Acura Pharmaceuticals reports Q1 net loss $0.28 per diluted share
02/05/2016 21:19
May 2 (Reuters) - Acura Pharmaceuticals Inc ACUR.O
* Reported net loss of $3.4 million for Q1 2016 or $0.28 per
diluted share
* Revenues for quarter were $0.2 million compared to $5.4
million in Q1 of 2015
Source text for Eikon: ID:nMKWKslYka
Further company coverage: ACUR.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way